Our Mission
Caeli Technologies was founded in 2021 in response to a critical U.S. DoD need for a 12-hour rebreather solution. Our mission is to empower those who protect us with life-saving breathing technology. We design and deliver next-generation rebreathers that enable military, first responders, and industrial teams to survive and succeed in the most hazardous environments. Every product is built with one goal in mind: keep the operator alive, breathing, and effective until the mission is complete. We are driven by the belief that extending the window of survivability directly translates to saved lives and mission success.
Our Innovative Team
Daniel Stapleton
Chief Executive Officer (CEO)
30 years of leadership in security and aviation, formerly serving as Director of Security and Director of International affairs at El Al Airlines, and as an IDF Special Forces unit commander.
Arie Kalo
President & CTO
A visionary high-tech entrepreneur specializing in medical devices, security products and startup companies. Founder of Laser Modeling, the largest 3D printing service bureau in Israel. Co-founded Sabrafence Technologies, a leader in sophisticated perimeter security sensors. Former IDF special forces officer.
Nir Bloch
Chief Science Officer
A veteran Israel Navy SEALs officer and mechanical engineer with 30+ years developing rebreathing systems for the IDF.
Uzi Barzilay
SVP & COO
A former Head of Countermeasures at Israel’s ISA (Shin Bet) with over 30 years leading high-risk intelligence and security operations.
Amit Afrik
Chief Customer Officer (CCO)
Avid diver and experienced instructor. Former Israel Navy Seals Team Leader with 19 years of service in IDF Flotilla 13. R&D developer for underwater systems and platforms A-Z. Partnered with industry innovators like Alon Technologies. Created cutting-edge underwater systems. Icon in the world of underwater technology.
We are mission-focused and operator-centric in everything we do
Our core values include
Innovation & Excellence
We constantly push the boundaries of breathing technology (such as inventing the first hybrid PAPR/CCBA rebreather) to give users a decisive edge. Quality and reliability are non-negotiable – lives depend on our gear performing flawlessly under pressure.
Survivability
We prioritize solutions that protect life in extreme conditions. Whether in combat or disaster response, Caeli systems are engineered to maximize survivability and endurance for the operator and those they may rescue.
Integrity & Trust
We deeply honor the trust our users place in us. Many of us come from the communities we serve – military, rescue, law enforcement – and we instill integrity in our work, testing rigorously and delivering on promises.
Collaboration
We work closely with defense agencies, first responder units, and industry partners worldwide. By listening to end-user feedback and fostering open collaboration, we ensure our products truly meet real-world needs (our ongoing partnerships with the U.S. DoD’s IWTSD and Israel’s DDR&D are prime examples).
Global Security
We are committed to strengthening global defense and public safety. From the U.S. and NATO allies to developing nations, our vision is to equip those on the front lines of global security and emergency response with the best breathing apparatus technology available.
Transparency
We believe trust is earned through openness. In an industry where discretion and security are paramount, Caeli is committed to clear communication with our partners, clients, and end-users—sharing data, performance, and results with integrity. Transparency ensures accountability in every mission we support, and reinforces the confidence operators place in our systems.
History & Milestones
In less than two years since our founding, Caeli has progressed from concept to operationally proven systems. We delivered our first rebreathers in 2023, and they have already been successfully deployed in live missions by special operations and response units worldwide.
This rapid validation under fire (achieving TRL 9 operational readiness) underscores our team’s unique ability to innovate swiftly and effectively. We continue to scale production and global outreach – on track to capture ~5% of the US/EU breathing apparatus market by 2030 with our expanded product line.
